Why trade compliance deviations Happens in Import Export Compliance Issues and How to Fix It


Published on 18/06/2026

Understanding and Addressing Compliance Deviations in Pharma Import and Export Operations

Compliance deviations in the pharma import-export sector can significantly impact the smooth functioning of operations, jeopardizing regulatory adherence and business integrity. This case study explores a hypothetical yet realistic scenario faced by a pharmaceutical company, detailing the steps taken from detection of the issue to the implementation of corrective and preventive actions (CAPAs). By examining the pathway through symptoms, causes, resolution strategies, and lessons learned, professionals will acquire practical insights to optimize their compliance processes.

This article aims to empower pharmaceutical manufacturing and quality professionals with knowledge on how to detect and rectify import-export compliance issues while ensuring adherence to regulatory frameworks. You will learn about containment strategies, investigation methodologies, and the importance of thorough documentation in maintaining compliant operations.

Symptoms/Signals on the Floor or in the Lab

In a manufacturing facility, compliance deviations often manifest through various indicators within the operational workflow. For the pharmaceutical company in our case study, deviations occurred during the import of raw materials required for production. Symptoms

included:

  • Delayed Shipments: Incoming shipments of active pharmaceutical ingredients (APIs) were regularly delayed, causing production downtime. This raised immediate red flags about potential non-compliance with customs regulations.
  • Document Discrepancies: Anomalies were noted between the shipping documents and the purchase orders, notably in customs documentation and associated permits.
  • Increased Inquiry Rates: There was a noticeable increase in queries from customs officials, leading to a higher number of shipments being held for review.
  • Audit Findings: Previous internal audits had increasingly flagged issues with import licenses and compliance to regulations set by authorities such as the FDA or EMA.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

To analyze the situation effectively, we categorized potential causes of these compliance deviations into six key areas:

Category Potential Causes
Materials Improper or incomplete documentation for controlled goods logistics.
Method Inadequate procedures for preparing customs documentation and verifying import licenses.
Machine No specific failures noted; however, digital systems for tracking imports lacked integration.
Man Lack of training among staff regarding compliance requirements and documentation processes.
Measurement Incomplete quality checks leading to failures in identifying discrepancies in import conditions.
Environment Changes in regulatory landscapes impacting compliance standards and import/export agreements.
Pharma Tip:  Preventive Controls for export shipment holds in Import Export Compliance Issues

Immediate Containment Actions (first 60 minutes)

Upon detection of the compliance deviations, the first step was to initiate immediate containment actions. This included:

  • Stop All Affected Shipments: Immediate halt of all ongoing import processes related to flagged APIs, preventing further complications.
  • Document Review: Gather and review all import documentation associated with shipments under scrutiny, focusing on customs documentation accuracy and alignments with import licenses.
  • Notify Stakeholders: Inform all relevant departments, including Quality Assurance (QA), Regulatory Affairs (RA), and Import-Export Logistics, about the situation to mobilize collective troubleshooting efforts.
  • Engage Customs Officials: Initiate communication with customs officials to assess held shipments and clarify necessary actions for compliance.
  • Establish a Communication Plan: Develop a strategy for internal and external communication to keep relevant stakeholders updated on progress and findings.

Investigation Workflow (data to collect + how to interpret)

The second phase involved performing a detailed investigation of the detected compliance issues. The following steps were taken during the investigation workflow:

  • Data Collection: All relevant documentation, including import licenses, customs declarations, invoices, and shipment logs, were collected for review.
  • Audit Past Records: Previously filed customs documents were audited to identify patterns and potential recurring issues.
  • Conduct Interviews: Staff involved in the import-export process were interviewed to uncover gaps in training or understanding of compliance requirements.
  • Document Findings: Findings were documented in a comprehensive report to capture insights and recommended actions.

The analysis revealed inconsistencies primarily due to a lack of clarity in procedures and insufficient staff training on current regulation changes affecting import-export operations.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Effective root cause analysis (RCA) is critical for identifying the fundamental causes of compliance deviations. In this scenario, the following tools were employed:

  • 5-Why Analysis: This method traced the problem back through successive “why” questions. For example, why customs documentation was incorrect led to why staff were unaware of regulations, revealing a training gap.
  • Fishbone Diagram: A visual representation helped categorize and identify potential causes by the 6 Ms (Materials, Methods, Machines, Manpower, Measurements, Environment). It proved valuable for organizing thoughts systematically.
  • Fault Tree Analysis: This tool was utilized to analyze the pathways leading to compliance failures and understand the interconnections among identified causes.

Using these tools collaboratively ensured a comprehensive understanding of the root causes and informed the development of CAPAs.

Pharma Tip:  How to Link Import Export Compliance Issues with QMS CAPA and Change Control

CAPA Strategy (correction, corrective action, preventive action)

A robust CAPA strategy was developed based on the findings of the RCA. This strategy consisted of three critical elements:

  • Correction: Immediate rectifications were made to the affected shipments, including resubmission of accurate customs documentation and updated import licenses.
  • Corrective Action: Initiated a thorough review of operating procedures relevant to the import-export process. This led to drafting a revised standard operating procedure (SOP) encompassing updated regulatory changes.
  • Preventive Action: Introduced mandatory training sessions for all staff involved in the import-export process to enhance understanding of pharma import export compliance and customs documentation requirements.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

In order to prevent recurrence, a control strategy was instituted, including:

  • Statistical Process Control (SPC): Implemented monitoring mechanisms to track compliance-related metrics within the import-export operations. This included trends in shipping delays and customs inquiry rates.
  • Scheduled Sampling: Conducted regular sampling and review of shipment documentation to ensure compliance and prevent potential non-conformities before they occur.
  • Alerts and Alarms: Established an alert system for deviations in shipping dates, incorrect documentation submissions, or alterations in import license statuses.
  • Verification Processes: Instituted regular audits and inspections to verify the accuracy of documentation and compliance with regulatory requirements.

Validation / Re-qualification / Change Control impact (when needed)

Changes resulting from the investigation necessitated validation and potential change control. This included the following actions:

  • Review of Affected Processes: An evaluation of previously validated systems was conducted to ensure no impacts arose from the implemented changes.
  • Re-qualification of Processes: Certain processes related to document handling and training were identified as needing re-qualification due to changes in procedures, which promptly underwent review.
  • Change Control Assessments: Executed formal change control assessments for any updates to procedures, ensuring compliance with internal and external regulatory frameworks.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

Being prepared for inspection is crucial for any pharmaceutical operation. In our case study, the following documentation was prepared to demonstrate compliance and operational integrity:

Related Reads

  • Training Records: Documentation of all training sessions held post-issue to ensure personnel were informed of compliance requirements.
  • Updated SOPs: Newly drafted and formally approved standard operating procedures outlining revised compliance protocols.
  • Import Documentation Logs: Records show revisions made to shipments-specific import licenses and customs documentation for traceability.
  • CAPA Records: Clear documentation of the CAPA process, including root cause analysis findings and evidence of corrective and preventive measures taken.
  • Internal Audit Reports: Recent audit findings demonstrating that the issues were addressed and improvements implemented to prevent future occurrences.
Pharma Tip:  CAPA Strategy for import permit delays in Import Export Compliance Issues

FAQs

What are common compliance violations in pharma import export?

Common violations include incorrect customs documentation, missing import licenses, and discrepancies between shipment contents and declared values.

How can I ensure compliance with changing regulations?

Regular training for staff, adherence to updated SOPs, and collaboration with regulatory experts can help ensure ongoing compliance amidst changing regulations.

What immediate steps should I take upon detecting a compliance issue?

Cease affected operations, review related documentation, notify relevant stakeholders, and communicate with customs officials as needed.

How often should training be conducted for compliance staff?

Training should be conducted at least annually, with additional sessions as regulations change or new processes are implemented.

What key documents should be maintained for inspection readiness?

Keep detailed records of training, audit results, CAPA actions, SOPs, and all relevant import-export documentation accessible for inspection.

When should I implement a change control process?

A change control process should be implemented whenever there are changes to compliant procedures, equipment, or staffing that affects the quality system.

How can I measure the effectiveness of my CAPA strategy?

Monitor key performance indicators such as compliance rates, incident recurrences, and process improvement metrics to assess CAPA effectiveness.

What role does management play in compliance strategies?

Management is pivotal in endorsing compliance culture, supporting training initiatives, and providing resources for effective operational execution.

Is it necessary to involve legal counsel in compliance issues?

Yes, legal counsel can provide critical guidance on regulatory requirements and implications of compliance deviations.

How can I keep abreast of regulatory changes?

Subscribe to updates from regulatory bodies such as the FDA, EMA, and ICH, and participate in industry forums and seminars.

Are third-party audits beneficial for ensuring compliance?

Yes, third-party audits offer an impartial perspective on compliance practices, highlight areas for improvement, and can bolster internal audit processes.

What steps are taken if repeated violations occur?

Repeated violations could lead to a comprehensive audit, potential penalties or fines, and a complete revision of the compliance processes.

If you find our Articles useful
Add us as preferred source on Google
If you find our Articles useful
Add us as preferred source on Google